FDA — authorised 6 March 2018
- Marketing authorisation holder: TAIMED BIOLOGICS USA
- Status: approved
🇺🇸 Trogarzo in United States
FDA authorised Trogarzo on 6 March 2018
Marketing authorisations
FDA — authorised 12 December 2023
- Application: BLA761065
- Marketing authorisation holder: THERATECHNOLOGIES
- Indication: Labeling
- Status: approved
Trogarzo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Trogarzo approved in United States?
Yes. FDA authorised it on 6 March 2018; FDA authorised it on 12 December 2023.
Who is the marketing authorisation holder for Trogarzo in United States?
TAIMED BIOLOGICS USA holds the US marketing authorisation.